Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors

Human Molecular Genetics

Volumn 20, Issue 1, 2011, Pages 165-175

  Almeida, Madson Q ^a   Tsang, Kit Man ^a   Cheadle, Chris ^d   Watkins, Tonya ^d   Grivel, Jean Charles ^b   Nesterova, Maria ^a   Goldbach Mansky, Raphaela ^c   Stratakis, Constantine A ^a,b  

^a Program on Developmental Endocrinology and Genetics (PDEGEN)   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTERLEUKIN 1BETA CONVERTING ENZYME; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR ETS; WNT PROTEIN; INFLAMMASOME; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ETS 1; WNT1 PROTEIN; WNT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE LESION; CELL PROLIFERATION; CINCA SYNDROME; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; STEM CELL; STROMA CELL; TUMOR CELL; WNT SIGNALING PATHWAY; ANIMAL; BONE; CELL CULTURE; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

MUS;

ANIMALS; BONE AND BONES; CASPASE 1; CELLS, CULTURED; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; HUMANS; INFLAMMASOMES; MICE; OSTEOBLASTS; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELLS; STROMAL CELLS; TRANSCRIPTIONAL ACTIVATION; WNT1 PROTEIN;

EID: 79956313489     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq455     Document Type: Article

References (50)

1. Kirschner, L.S., Kusewitt, D.F., Matyakhina, L., Towns, W.H. II, Carney, J.A., Westphal, H. and Stratakis, C.A. (2005) A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res., 65, 4506-4514.
2. Carney, J.A., Boccon-Gibod, L., Jarka, D.E., Tanaka, Y., Swee, R.G., Unni, K.K. and Stratakis, C.A. (2001) Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am. J. Surg. Pathol., 25, 164-176.
3. Stratakis, C.A., Kirschner, L.S. and Carney, J.A. (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab., 86, 4041-4046.
4. Pavel, E., Nadella, K., Towns, W.H. II and Kirschner, L.S. (2008) Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A. Mol. Endocrinol., 22, 430-440.
5. Tsang, K.M., Starost, M.F., Nesterova, M., Boikos, S.A., Watkins, T., Almeida, M.Q., Harran, M., Li, A., Collins, M.T., Cheadle, C. et al. (2010) Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone. Proc. Natl Acad. Sci. USA, 107, 8683-8688.
6. Hill, S.C., Namde, M., Dwyer, A., Poznanski, A., Canna, S. and Goldbach-Mansky, R. (2007) Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr. Radiol., 37, 145-152.
7. Aksentijevich, I., Nowak, M., Mallah, M., Chae, J.J., Watford, W.T., Hofmann, S.R., Stein, L., Russo, R., Goldsmith, D., Dent, P. et al. (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum., 46, 3340-3348.
8. Feldmann, J., Prieur, A.M., Quartier, P., Berquin, P., Certain, S., Cortis, E., Teillac-Hamel, D., Fischer, A. and de Saint Basile, G. (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet., 71, 198-203.
9. Petrilli, V., Dostert, C., Muruve, D.A. and Tschopp, J. (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol., 19, 615-622.
10. Pei, H., Li, C., Adereth, Y., Hsu, T., Watson, D.K. and Li, R. (2005) Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis. Cancer Res., 65, 7205-7213.
11. Mouawad, R., Antoine, E.C., Gil-Delgado, M., Khayat, D. and Soubrane, C. (2002) Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapy. Melanoma Res., 12, 343-348.
12. Kleiveland, C.R., Kassem, M. and Lea, T. (2008) Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Exp. Cell Res., 314, 1831-1838.
13. Goessling, W., North, T.E., Loewer, S., Lord, A.M., Lee, S., Stoick-Cooper, C.L., Weidinger, G., Puder, M., Daley, G.Q., Moon, R.T. et al. (2009) Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell, 136, 1136-1147.
14. Li, T.F., Zuscik, M.J., Ionescu, A.M., Zhang, X., Rosier, R.N., Schwarz, E.M., Drissi, H. and O'Keefe, R.J. (2004) PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp. Cell Res., 300, 159-169.
15. Raouf, A. and Seth, A. (2000) Ets transcription factors and targets in osteogenesis. Oncogene, 19, 6455-6463.
16. Ting, J.P., Willingham, S.B. and Bergstralh, D.T. (2008) NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol., 8, 372-379.
17. Eisen, M.B., Spellman, P.T., Brown, P.O. and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.
18. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
19. Quarles, L.D., Yohay, D.A., Lever, L.W., Caton, R. and Wenstrup, R.J. (1992) Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res., 7, 683-692.
20. Sudo, H., Kodama, H.A., Amagai, Y., Yamamoto, S. and Kasai, S. (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol., 96, 191-198.
21. Dick, L.R., Cruikshank, A.A., Destree, A.T., Grenier, L., McCormack, T.A., Melandri, F.D., Nunes, S.L., Palombella, V.J., Parent, L.A., Plamondon, L. et al. (1997) Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem., 272, 182-188.
22. Yang, C., Shapiro, L.H., Rivera, M., Kumar, A. and Brindle, P.K. (1998) A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell Biol., 18, 2218-2229.
23. Park, J.Y., Pillinger, M.H. and Abramson, S.B. (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol., 119, 229-240.
24. Rabuffetti, M., Sciorati, C., Tarozzo, G., Clementi, E., Manfredi, A.A. and Beltramo, M. (2000) Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J. Neurosci., 20, 4398-4404.
25. Masumoto, J., Dowds, T.A., Schaner, P., Chen, F.F., Ogura, Y., Li, M., Zhu, L., Katsuyama, T., Sagara, J., Taniguchi, S. et al. (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem. Biophys. Res. Commun., 303, 69-73.
26. Dowds, T.A., Masumoto, J., Zhu, L., Inohara, N. and Nunez, G. (2004) Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem., 279, 21924-21928.
27. Hsu, T., Trojanowska, M. and Watson, D.K. (2004) Ets proteins in biological control and cancer. J. Cell Biochem., 91, 896-903.
28. Seth, A. and Papas, T.S. (1990) The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene, 5, 1761-1767.
29. Topol, L.Z., Tatosyan, A.G., Ascione, R., Thompson, D.M., Blair, D.G., Kola, I. and Seth, A. (1992) C-ets-1 protooncogene expression alters the growth properties of immortalized rat fibroblasts. Cancer Lett., 67, 71-78.
30. Seth, A. and Watson, D.K. (2005) ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer, 41, 2462-2478.
31. Kola, I., Brookes, S., Green, A.R., Garber, R., Tymms, M., Papas, T.S. and Seth, A. (1993) The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl Acad. Sci. USA, 90, 7588-7592.
32. Vary, C.P., Li, V., Raouf, A., Kitching, R., Kola, I., Franceschi, C., Venanzoni, M. and Seth, A. (2000) Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization. Exp. Cell Res., 257, 213-222.
33. Jayaraman, G., Srinivas, R., Duggan, C., Ferreira, E., Swaminathan, S., Somasundaram, K., Williams, J., Hauser, C., Kurkinen, M., Dhar, R. et al. (1999) p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter. J. Biol. Chem., 274, 17342-17352.
34. Goldbach-Mansky, R., Dailey, N.J., Canna, S.W., Gelabert, A., Jones, J., Rubin, B.I., Kim, H.J., Brewer, C., Zalewski, C., Wiggs, E. et al. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med., 355, 581-592.
35. Greenhough, A., Smartt, H.J., Moore, A.E., Roberts, H.R., Williams, A.C., Paraskeva, C. and Kaidi, A. (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
36. Horvath, A., Mathyakina, L., Vong, Q., Baxendale, V., Pang, A.L., Chan, W.Y. and Stratakis, C.A. (2006) Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. J. Clin. Endocrinol. Metab., 91, 584-596.
37. Almeida, M.Q., Muchow, M., Boikos, S., Bauer, A.J., Griffin, K.J., Tsang, K.M., Cheadle, C., Watkins, T., Wen, F., Starost, M.F. et al. (2010) Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/2 or Rb1+/2 backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling. Hum. Mol. Genet., 19, 1387-1398.
38. Iliopoulos, D., Bimpaki, E.I., Nesterova, M. and Stratakis, C.A. (2009) MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Res., 69, 3278-3282.
39. Bourdeau, I., Antonini, S.R., Lacroix, A., Kirschner, L.S., Matyakhina, L., Lorang, D., Libutti, S.K. and Stratakis, C.A. (2004) Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene, 23, 1575-1585.
40. Bimpaki, E.I., Iliopoulos, D., Moraitis, A. and Stratakis, C.A. (2009) MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumorigenesis. Clin. Endocrinol. (Oxf.), 72, 744-751.
41. Hsiao, H.P., Kirschner, L.S., Bourdeau, I., Keil, M.F., Boikos, S.A., Verma, S., Robinson-White, A.J., Nesterova, M., Lacroix, A. and Stratakis, C.A. (2009) Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J. Clin. Endocrinol. Metab., 94, 2930-2937.
42. Skalhegg, B.S., Huang, Y., Su, T., Idzerda, R.L., McKnight, G.S. and Burton, K.A. (2002) Mutation of the Calpha subunit of PKA leads to growth retardation and sperm dysfunction. Mol. Endocrinol., 16, 630-639.
43. Wang, X., Manner, P.A., Horner, A., Shum, L., Tuan, R.S. and Nuckolls, G.H. (2004) Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartil., 12, 963-973.
44. Cheadle, C., Nesterova, M., Watkins, T., Barnes, K.C., Hall, J.C., Rosen, A., Becker, K.G. and Cho-Chung, Y.S. (2008) Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cells. BMC Med. Genomics, 1, 43.
45. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
46. Nesterova, M., Yokozaki, H., McDuffie, E. and Cho-Chung, Y.S. (1996) Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta. Eur. J. Biochem., 235, 486-494.
47. Neary, C.L., Nesterova, M., Cho, Y.S., Cheadle, C., Becker, K.G. and Cho-Chung, Y.S. (2004) Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion. Oncogene, 23, 8847-8856.
48. Rohlff, C., Clair, T. and Cho-Chung, Y.S. (1993) 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J. Biol. Chem., 268, 5774-5782.
49. Guerrero, M.D., Aquino, M., Bruno, I., Terencio, M.C., Paya, M., Riccio, R. and Gomez-Paloma, L. (2007) Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression. J. Med. Chem., 50, 2176-2184.
50. Molyneux, S.D., Di Grappa, M.A., Beristain, A.G., McKee, T.D., Wai, D.H., Paderova, J., Kashyap, M., Hu, P., Maiuri, T., Narala, S.R. et al. (2010) Prkarla is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J. Clin. Invest., 120, 3310-3325.